Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility and Toxicity Study of Vaccination With HSP70 for the Treatment of Chronic Myelogenous Leukemia in the Chronic Phase

NCT00027144 is registered in ClinicalTrials.gov with University of Connecticut as lead sponsor.

NCT NCT00027144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00027144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility and Toxicity Study of Vaccination With HSP70 for the Treatment of Chronic Myelogenous Leukemia in the Chronic Phase
Lead sponsor
University of Connecticut
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2000
Completion date
October 31, 2002
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia,myeloid, chronic, leukemia,myeloid,philadelphia-positive